Purdue Pharma and Sackler Family Reach $7.4 Billion Settlement Over Opioid Crisis
Purdue Pharma and Sackler family agree to a $7.4 billion settlement to address opioid crisis lawsuits, subject to court approval.
Overview
Purdue Pharma and the Sackler family have agreed to pay up to $7.4 billion to settle lawsuits related to the opioid crisis, significantly increasing their previous settlement by over $1 billion. The Sacklers will contribute $6.5 billion and Purdue $900 million. This deal aims to compensate victims and fund opioid addiction treatment, but requires court approval. The arrangement ends Sackler control over Purdue and restricts them from selling opioids in the U.S. Several state attorney generals participated in this negotiation, seeing it as a means to provide some closure to opioid crisis victims.
Content generated by AI—learn more or report issue.
Get both sides in 5 minutes with our daily newsletter.
Analysis
Analysis unavailable for this viewpoint.
Articles (10)
Center (8)
No highlight available for this article.
Newsweek·5M·No highlight available for this article.
The Hill·5M·No highlight available for this article.
BBC News·5M·No highlight available for this article.
NBC News·5M·No highlight available for this article.
CBS News·5M·No highlight available for this article.
Newsweek·5M·No highlight available for this article.
CNBC·5M·No highlight available for this article.
Associated Press·5M·History
- 5M5 articles